Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
goldman small cap is going to put out a report on kaly. it is supposed to be more detailed on what is going on with kaly. when it comes out any good news could send this thing flying as kaly stated it will have info not put out yet by the company.
kaly already stated in the pr that there would not be a price target in the report. don't get peoples hopes up.
that is for sure. if atlanta is any clue to how the rest of the country will take it. I was checking on places everx is being sold. a couple of the stores told me cbd drinks are new but they are selling big time. if kaly can get drinks on the market in time to be one of the first this could be a gold mine. happy new years to all.
I hope they don't put out the report or any news Monday. it is new years eve. to many people will still be away and others on the road for the holiday. I would expect to see the report come out Wednesday or Thursday.
to show there are a lot of people gone for the holidays. look at most read and most posted. we are #12 most posted and only 260 post. normal would be in the 1000s. all I can say is don't sell for a loss before we see what next week brings. rules for trading are you are not allowed to buy a stock back for 30 days if you sell for a loss from what I remember. so if you sell now and we get good news and it goes up you will not be able to buy back in for 30 days. depending on what happens you could really regret it.
you have to love the way some go back and forth so much. it is the end of the year. a lot of tax selling not to mention all the ones that take the long Christmas news years holiday off. good chance that is why they are waiting for the new year to put out the goldman report. is it hard to see the pps at a lower price for now. yes. but I for one am holding strong until next week. don't know how long you have owned this stock or thinking about buying or selling. just have to ask your self if it is worth waiting till next week. I say yes for sure. glta.
Kali-Extracts Analyst Research Report From Goldman Small Cap Research Expected Next Week
DALLAS, TX -- December 28, 2018 -- InvestorsHub NewsWire -- Kali, Inc. (dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced an Analyst Research Report covering the company’s new business direction after acquiring a patented cannabis extraction operation is expected to be published next week. On November 15th, the company announced the acquisition of NCM Biotech in a transaction that changed the business direction of the company. After updating all required filings to bring the company into compliance with its required OTCMarkets reports, KALY management subsequently announced engaging Goldman Small Cap Research to initiative coverage of KALY’s new assets and business direction. The purpose of this report is to provide shareholders and interested investors more comprehensive information on the company’s current operations in a single document. The report will be filed on the OTCMarkets site. It will include detailed asset and business descriptions, operational financial analysis, comparisons to similar businesses, market forecasts and KALY specific forecasts. The purpose of the report is to enhance the OTCMarkets’ required disclosures by providing information on the current operations in addition to the OTCMarkets reports on historical operations.
Recent KALY milestones published by the company anticipated to be included in the analyst report include:
Kali-Extracts, Inc. Releases Preclinical Research Study Results on Therapy for Respiratory Disease Driving $11 Billion Treatment Market
Kali-Extracts Inc. Announces $300,000 Contract to Produce Hemp-Derived CBD Extract for Puration Inc.
KALY - Kali-Extracts Announces $100,000 Order of its Hemp4mula CBD Infused Chewing Gum Available Soon on USMJ E-commerce Site
Kali-Extracts and Nouveau Announce 100 Acer Hemp Farm and CBD Extraction Facility Made Possible By New Farm Bill
KALY produces pharmaceutical grade cannabis extracts that have been involved in multiple clinical trials in addition to utilizing its patented cannabis extraction process in the production of CBD infused nutrition and wellness products to include its own Hemp4mula and CBD infused waters produced by Puration, Inc. (USOTC: PURA) (“PURA”).
KALY is partners with PURA and Nouveau Life Pharmaceuticals (dba Nouveau) (USOTC: NOUV) (“NOUV”) in a joint venture named US Cannabis Health for the purpose of together developing partnerships with pharmaceutical companies to develop cannabis pharmaceuticals. US Cannabis Health recently announced its first agreement with Generex Biotechnology, Corp. (OTCQB: GNBT).
almost hit the .025 that you predicted.
here are some locations that carry everx. I was sent this list from savannah distributing.
littles food store
the tap on ponce
candler park market
bp gas station-3
main street citgo
bellas pizzeria
paces bottle shop
any one know where we can buy the happy water. they had an order for 100 pallets. must be somewhere we could go to buy it.
what about the telluride happy water. they had an order for 100 pallets. any one know where we can buy some.
if you went into the store and took pictures. did you ask about sales.
just got off the phone with savannah distributing. I was told there are ten locations that are carrying everx. 3 different flavors. was unable to tell me if they are selling good or not. having the purchase department call me back to see if I can find out how well it is selling. hope this helps. they are also going to email me a list of the stores that are selling it.
do not like the fact that they put out a tweet about a string of positive developments and then we get nothing positive out of them. claimed they had an order for 100 pallets of happy water. where is it being sold. that is something they should tell the investors should be no secret if they want it to sell. I would like to try it but have no idea where it is being sold. what stores has savanna distributing been able to get everx into would also like to try that. give us an update on where these items can be bought.
USMJ PURA KALY and MJNA Rated BULLISH In Anticipation of 2019 HEMP BOOM
New York, NY -- December 27, 2018 -- InvestorsHub NewsWire -- via NextBigTicker.com -- North American Cannabis Holdings, Inc. (USOTC:USMJ), Puration, Inc. (USOTC: PURA), Kali, Inc. (USOTC: KALY) and Medical Marijuana, Inc. (USOTC: MJNA) have all been rated BULLISH by Stock Technical Analysis (Stockta.com). The cannabis sector, particularly companies with a strong hemp related presence, have seen increased investment interest since President Trump signed the Farm Act into law legalizing hemp farming.
PURA, In fact, has been rated VERY BULLISH having established a substantial support base at $0.08 after pulling back from a 52-week high of $0.25 and now showing signs of rebounding to its $0.25 52-week high.
USMJ has recently broken out on high volume. The PPS has made a dramatic move above $0.001. The 52-week high is $0.0025. The company has recently announced a $10 million revenue goal for 2019 based on its new ecommerce business. The company has also announced a pending dividend. With a positive cannabis market and progress toward the $10 million revenue goal, the USMJ PPS has the potential to break above $0.01.
KALY has recently acquired a patented cannabis extraction process changing its entire business. The company has announced $400,000 in contracts since making the acquisition. The company has also released pre-clinical research on cannabis extracts from its patented process conducted in partnership with universities. KALY is trading in the $0.02 to $0.03 range and a PPS of $0.10 would not be a surprise.
MJNA is also rated VERY BULLISH with a PPS currently trading at $0.08 with a 52 week high of $0.18. With the positive cannabis sector environment resulting from the recent passage of the Farm Act combined with MJNA’s steady business plan, MJNA seems set for a rebound to it $0.18 52-week high.
USMJ PURA KALY and MJNA Rated BULLISH In Anticipation of 2019 HEMP BOOM
New York, NY -- December 27, 2018 -- InvestorsHub NewsWire -- via NextBigTicker.com -- North American Cannabis Holdings, Inc. (USOTC:USMJ), Puration, Inc. (USOTC: PURA), Kali, Inc. (USOTC: KALY) and Medical Marijuana, Inc. (USOTC: MJNA) have all been rated BULLISH by Stock Technical Analysis (Stockta.com). The cannabis sector, particularly companies with a strong hemp related presence, have seen increased investment interest since President Trump signed the Farm Act into law legalizing hemp farming.
PURA, In fact, has been rated VERY BULLISH having established a substantial support base at $0.08 after pulling back from a 52-week high of $0.25 and now showing signs of rebounding to its $0.25 52-week high.
USMJ has recently broken out on high volume. The PPS has made a dramatic move above $0.001. The 52-week high is $0.0025. The company has recently announced a $10 million revenue goal for 2019 based on its new ecommerce business. The company has also announced a pending dividend. With a positive cannabis market and progress toward the $10 million revenue goal, the USMJ PPS has the potential to break above $0.01.
KALY has recently acquired a patented cannabis extraction process changing its entire business. The company has announced $400,000 in contracts since making the acquisition. The company has also released pre-clinical research on cannabis extracts from its patented process conducted in partnership with universities. KALY is trading in the $0.02 to $0.03 range and a PPS of $0.10 would not be a surprise.
MJNA is also rated VERY BULLISH with a PPS currently trading at $0.08 with a 52 week high of $0.18. With the positive cannabis sector environment resulting from the recent passage of the Farm Act combined with MJNA’s steady business plan, MJNA seems set for a rebound to it $0.18 52-week high.
have to say I am disappointed myself. to put out the tweet about all the developments and then the news they put out is about what another company did. make it look like a desperation move to have something to put out.
on the other hand profit takers make a stock stronger. get good news and the stock is in stronger hands. been saying for a while something is up. when the hole thing unfolds would love to see this in stronger hands and the flippers left behind.
looks like a small gap up this morning.
nice way to start the morning. 500,000 buy pre market. hope there is more.
thank you for the info. do you have the link to get the program? and for now where do you see the pps going. thanks again.
pura tweeted yesterday. string of positive developments supports bounce back to 50 week high of $.25 looks like we may have a good week here. bet nouv will be mentioned. this is a hole new game. I will not flip this one. this is like being on the ground floor when the internet came out. very low priced not worth missing out. you could sell and a couple minutes later huge news hits. they halt the stock for a trading imbalance and it opens much higher. do not want to take the chance. this is now a hole new sector for the market and some of these very small companies are going to make it big. good luck to all.
pura tweeted yesterday. string of positive developments supports bounce back to 50 week high of $.25 looks like we may have a good week here. bet some of it will have to do with usmj. all this volume and pps going up there has to be something going on. good luck to all. going to be hard to sleep this week waiting on news.
pura tweeted yesterday. string of positive developments supports bounce back to 50 week high of $.25 looks like we may have a good week here. bet kaly will have something to do with it.
pura tweeted yesterday. string of positive developments supports bounce back to 50 week high of $.25 looks like we may have a good week here.
not trying to argue with you but you stated they are keeping the share holders informed. please show me what I missed. a couple weeks ago he tweeted that we would get an update Tuesday that never happened. he tweeted pull steam ahead. full steam ahead on what. he said the stock is holding up strong all I see is it going down every day. so please show me where he is keeping us informed. so you know I hope the best for this stock. like the others I have not sold a single share incase it turns around. but to this point I am disappointed with the tweets and no real info to keep us informed. in any case good luck to all and may this hit silver.
in the past or other stocks that is the way to go. but like computers and internet this is new to the market. we are at the beginning. the ones that pull it together are going to become very well know and make owners of the stocks at these dirt cheap prices rich if they pick the wright ones. do not know if evsv is still working with usmj nouv kaly pjet. I can tell you the other ones are moving and evsv is not. makes me feel like they lost ties with this hole deal. all we get are tweets and no real info. but if you hold any of these it might be a good idea to change your trading strategy this time. I have been holding all of them and the only one that is doing bad is evsv. motley fool just came out with an article on kaly the other day and we are waiting on the goldman report to come out any day that should give a better idea of what is going on. so good luck to all this new year.
I have asked the same thing. with all the pr's evsv has not been mentioned. the other ones are getting good volume and moving up. evsv is sinking. all we have gotten out of them is some stupid tweets. for the other ones to move like they are and evsv is falling behind makes me believe more that something is up and we will see some news that will make these stocks fly. the big picture has yet to reveled.
do not understand this chart. could you please explain it. and with our share structure what is the highest price any one believes this can go.
if any one belongs to motley fool it would be nice if they could post the article. looks like they are saying kaly is #4 of #7 for their top stocks of 2019 I would guess they believe the ce is going to come down as it does not bother them to pick kaly as one of the biggest stocks for next year. this just keeps getting better. cant wait for the hole picture to unfold. and would love to know what price target motley has for kaly.
the only difference will be goldman gave a price target for pura. they will not have a price target for kaly from what kaly wrote in the pr.
would not care if they issued stock. it takes money to grow. would rather see a little dilution then go somewhere and borrow with interest. on another note look at their partners usmj and nouv both having very strong day for a short day.
and they would not be taking this big of a chance of going to prison on a huge scam. the report is important in more ways then one.
when the goldman report comes out it should show they are not spending all this time and money for nothing.
here re read this. it will tell you they have talked to the otc and will need the goldman report to give the otc the rest of the info they need.
DALLAS, Dec. 18, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced posting all filings required by OTCMarkets under its OTC Pink – Current Information Tier standards. On November 15th, the company announced the acquisition of NCM Biotech in a transaction that changed the business direction of the company. Prior to that acquisition, the company’s previous business focus on marina management had languished. In addition to the marina management business not advancing as originally planned, the company had fallen behind in the timely filing of the disclosures required by OTCMarkets. The company has now caught up on all its past due filing requirements. However, the information posted on OTCMarkets to meet the OTC Pink Current Information standard does not include much information on the current business. Accordingly, management has engaged Goldman Small Cap Research to initiative coverage of KALY’s new assets and business direction. The purpose of this report is to provide shareholders and interested investors more comprehensive information on the company’s current operations in a single location. The report will be filed on the OTCMarkets site. It will include detailed asset and business descriptions, operational financial analysis, comparisons to similar businesses, market forecasts and KALY specific forecasts. The report will not at this time include an investment recommendation or share price target. The purpose of the report is to enhance the OTCMarkets’ required disclosures by providing information on the current operations in addition to the OTCMarkets reports on historical operations.
On December 14th, 2018, KALY released a Letter to Shareholders reconfirming recent acquisition, contract and partnership announcements. The letter was issued in response to an OTCMarkets investor precaution published the previous day. Management has talked with an OTCMarkets representative who expressed concern regarding the recent increase in KALY news and a corresponding increase in trading volume. KALY management contends the news and trading volume increase are simply a factor of the company’s recent acquisition of NCM Biotech and the corresponding business direction change. In addition to efforts such as the updated OTCMarkets filings, the Friday Shareholder Letter and the Analyst Research Coverage engagement, all intended to enhance transparency, KALY management will diligently endeavor to explore, understand and resolve the OTCMarkets concerns that resulted in their issuance of the Caveat Emptor investor precautionary flag.
The Friday Shareholder Letter has been included again below in its entirety in an ongoing initiative to enhance transparency particularly in the instance of recent business updates.
From Current CEO Charles Yawn With Introduction Of Incoming CEO Frederick Ferri
Dear Shareholders and Interested Investors:
I am encouraged by the caliber of KALY’s recent acquisition and enthusiastic about the new business direction. I love boating and marinas and I’m disappointed that our marina management business did not flourish as anticipated. However, I believe the rapidly evolving legal cannabis sector is a marketplace rich with opportunity and that KALY’s recent acquisition will be much more than a mere consolation prize for shareholders. I am pleased to introduce the incoming CEO, Frederick Ferri, the founder of NCM Biotech and the individual behind the patented cannabis extraction technology that is now a KALY asset as a result of the acquisition of NCM Biotech announced on November 15th, just less than one month ago:
Kali Inc Acquires Patented Cannabis Extraction Operation Entering $50 Billion Pharmaceutical Market and $8 Billion Concentrates Market
I am staying with KALY as the Chairman while Mr. Ferri assumes the CEO position to lead the new cannabis extraction business operations. My ongoing role is to support Mr. Ferri with my pubic company management experience permitting Mr. Ferri to concentrate on the operational development of his cannabis extraction business plan.
Mr. Ferri is moving fast in the execution of his business plan. He has fostered a business relationship that he brought with his company NCM Biotech, that KALY acquired. NCM Biotech had licensed its patented extraction process to Puration, Inc. (PURA) for the production of a CBD infused beverage called EVERx. Now KALY is working with PURA to produce new CBD infused beverages. PURA has engaged KALY to make custom hemp-derived CBD extracts for a private label CBD infused water that PURA will produce for a client pharmaceutical company:
Kali-Extracts Inc. Announces $300,000 Contract to Produce Hemp-Derived CBD Extract for Puration Inc.
KALY has also entered a joint venture (JV) agreement with Puration and two additional partners to develop partnerships with pharmaceutical companies for the ultimate purpose of developing cannabis based pharmaceutical products:
Puration, Kali and Nouveau Announce Healthcare Industry Veteran Steven Rash as CEO of US Cannabis Health JV
The JV has already entered into its first agreement with a pharmaceutical client company. The client company is the same company for which PURA and KALY are producing a private label CBD infused water. KALY is already preparing to file for additional patents in conjunction with existing research it has conducted with its current patented extraction process. The additional patent filings are intended to support the JV’s objectives:
Puration and Kali Plan to Submit New Patent Applications in Conjunction with Generex Agreement
In an effort to develop sustainable near-term revenue, KALY has initiated an effort to produce its own line of CBD candies and vapes targeting the wellness market:
Kali Inc Introduces HEMP4MULA CBD Infused Candies and Vapes Into $22 Billion Hemp-Derived CBD Market
KALY has come a long way in the last month since the acquisition of NCM Biotech. We where already behind on our disclosures with OTCMarkets with the languishing of our marina management business. All the progress in the last month without rectifying previous delinquencies, can only exacerbate OTCMarkets concerns on behalf of investors.
We plan to have the past-due filings updated promptly. The filings are already prepared to be filed. I confess that part of the current delinquency was due to being behind on our OTCMarket bills. I am happy to say we are now current on payments to OTCMarkets and expect to begin updating filings today.
To supplement the precautionary warnings issued by OTCMarkets, I want to conclude by pointing out that even when KALY finishes updating all its past-due filings, which we expect to do by no later than close of business on Monday, all those filings will only include information on the languishing marina business. The updated filings will include very little information on the new cannabis extraction business. The new business information will be a topic of future filings with OTCMarkets. In the meantime, it will be important for investors to look for supplemental sources of information. For instance, from KALY press releases and from the new KALY website – www.kali-extracts.com.
In an effort to provide further information on KALY’s new business, we have engaged an independent analyst to compose a research report on the company. Yes, we are paying for the research and the conclusions of the analyst are subject to the scrutiny that KALY management may have influenced the analyst’s conclusions. I will tell you that is not the case. We will not interfere with the analyst’s independent analysis. You can decide whether or not to believe me. In any case, the analyst’s report will include a detailed description of the company’s assets, contracts and developments that will provide investors consolidated information on the company that is likely not available in a single source anywhere else. We will post the analyst report on the company’s website. We expect to have it by the end of next week.
Thank you for your time, interest and attention.
buy and sells are close. a little over 15 million in buys and sells.
wow almost 170 in buys and only 17 million in sells. great day.
if you read the pr kaly put out. they stated that the filings they where putting out now would not be enough for the otc. the rest of the information they believe the otc would need will be in the goldman report. that is why I want to see the report come out. then it could be up to 30 days from that point for the ce to be removed.
sure would be a nice Christmas gift from kaly to put out the goldman report today.
who is buying 4999 shares at a time several of them